These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2384864)

  • 41. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: long-term experience.
    Smiley L
    J Infect; 1989 Jan; 18 Suppl 1():77. PubMed ID: 2644363
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3'-azido-2',3'-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. A pilot study.
    Surbone A; Yarchoan R; McAtee N; Blum MR; Maha M; Allain JP; Thomas RV; Mitsuya H; Lehrman SN; Leuther M
    Ann Intern Med; 1988 Apr; 108(4):534-40. PubMed ID: 2964805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation.
    Crumpacker C; Heagy W; Bubley G; Monroe JE; Finberg R; Hussey S; Schnipper L; Lucey D; Lee TH; McLane MF
    Ann Intern Med; 1987 Nov; 107(5):664-74. PubMed ID: 3662279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
    Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P
    Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Compliance with AZT treatment regimen of HIV-seropositive injection drug users: a neglected issue.
    Freeman RC; Rodriguez GM; French JF
    AIDS Educ Prev; 1996 Feb; 8(1):58-71. PubMed ID: 8703641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).
    Yarchoan R; Perno CF; Thomas RV; Klecker RW; Allain JP; Wills RJ; McAtee N; Fischl MA; Dubinsky R; McNeely MC
    Lancet; 1988 Jan; 1(8577):76-81. PubMed ID: 2891981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma.
    Fischl MA; Uttamchandani RB; Resnick L; Agarwal R; Fletcher MA; Patrone-Reese J; Dearmas L; Chidekel J; McCann M; Myers M
    J Acquir Immune Defic Syndr (1988); 1991; 4(1):1-10. PubMed ID: 1670585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus.
    Richman DD; Grimes JM; Lagakos SW
    J Acquir Immune Defic Syndr (1988); 1990; 3(8):743-6. PubMed ID: 2114476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Zidovudine use in AIDS-free HIV-1-seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989.
    Graham NM; Zeger SL; Kuo V; Jacobson LP; Vermund SH; Phair JP; Detels R; Rinaldo CR; Saah AJ
    J Acquir Immune Defic Syndr (1988); 1991; 4(3):267-76. PubMed ID: 1671411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group.
    Spruance SL; Pavia AT; Mellors JW; Murphy R; Gathe J; Stool E; Jemsek JG; Dellamonica P; Cross A; Dunkle L
    Ann Intern Med; 1997 Mar; 126(5):355-63. PubMed ID: 9054279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hematologic toxicity of zidovudine in HIV-infected patients.
    Brogan KL; Zell SC
    Am Fam Physician; 1990 May; 41(5):1521-8. PubMed ID: 1692180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current and future trials with zidovudine.
    Yeo JM
    J Infect; 1989 Jan; 18 Suppl 1():93-6. PubMed ID: 2644366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
    Collier AC; Bozzette S; Coombs RW; Causey DM; Schoenfeld DA; Spector SA; Pettinelli CB; Davies G; Richman DD; Leedom JM
    N Engl J Med; 1990 Oct; 323(15):1015-21. PubMed ID: 1977080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. AIDS Clinical Trials Group: phase I/II study of combination 2',3'-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.
    Meng TC; Fischl MA; Richman DD
    Am J Med; 1990 May; 88(5B):27S-30S. PubMed ID: 2159707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A cohort study of drug users' compliance with zidovudine treatment.
    Broers B; Morabia A; Hirschel B
    Arch Intern Med; 1994 May; 154(10):1121-7. PubMed ID: 8185425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of zidovudine therapy in minority and other subpopulations with early HIV infection.
    Lagakos S; Fischl MA; Stein DS; Lim L; Volberding P
    JAMA; 1991 Nov; 266(19):2709-12. PubMed ID: 1942422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors influencing outcome of treatment with zidovudine of patients with AIDS in Australia. The Australian Zidovudine Study Group.
    Swanson CE; Cooper DA
    AIDS; 1990 Aug; 4(8):749-57. PubMed ID: 1979744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
    Henry DH; Beall GN; Benson CA; Carey J; Cone LA; Eron LJ; Fiala M; Fischl MA; Gabin SJ; Gottlieb MS
    Ann Intern Med; 1992 Nov; 117(9):739-48. PubMed ID: 1416576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex.
    Pinching AJ; Helbert M; Peddle B; Robinson D; Janes K; Gor D; Jeffries DJ; Stoneham C; Mitchell D; Kocsis AE
    J Infect; 1989 Jan; 18 Suppl 1():33-40. PubMed ID: 2521663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017).
    Mulder JW; Cooper DA; Mathiesen L; Sandström E; Clumeck N; Gatell JM; French M; Donovan B; Gray F; Yeo JM
    AIDS; 1994 Mar; 8(3):313-21. PubMed ID: 7913326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.